Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925765 · ClinicalTrials.gov registry record · NA
Virtual Reality Biofeedback for Postpartum Anxiety and Depression
A NA study, sponsored by Grace Lim, MD, MS.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04925765: Completed NA study, sponsored by Grace Lim, MD, MS.
NCT04925765 is a NA study that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04925765, a NA study, has completed, sponsored by Grace Lim, MD, MS.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to test patient feasibility and acceptability of virtual reality biofeedback program in postpartum women for anxiety and depression outcomes.
Primary Outcome
Patient response to the feasibility of VR use. The question asked was, "I was able to do the session without difficulty," which was measured on a Likert Scale of 1-5. A score of 1 is indicative of great difficulty present and a score of 5 is indicative of no difficulty present. Outcome measurement is presented as an averaged score with standard deviation among participating patients.
Interventions
- OTHER Virtual Reality Biofeedback Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2021-10-15 |
| Phase | NA |
What the finished NCT04925765 record still lists
NCT04925765 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Biofeedback Session is the first listed.
NCT04925765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04925765 about?
NCT04925765 is a clinical study titled "Virtual Reality Biofeedback for Postpartum Anxiety and Depression". The purpose of this study is to test patient feasibility and acceptability of virtual reality biofeedback program in postpartum women for anxiety and depression outcomes.
What is the current status of trial NCT04925765?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-09-01. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT04925765?
The interventions under investigation include: Virtual Reality Biofeedback Session (OTHER).
Who is sponsoring clinical trial NCT04925765?
This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04925765's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI